Last update 23 Jan 2025

CD56 x Top I

Basic Info

Related Targets
CD56Top I

Related

1
Drugs associated with CD56 x Top I
Anti-CD56-CPT113 ADC(Hangzhou DAC Biotechnology)
Target
CD56 x Top I
Mechanism
CD56 inhibitors [+1]
Active Org.
Hangzhou DAC Biotechnology Co., Ltd.Hangzhou DAC Biotechnology Co., Ltd.
Originator Org.
Hangzhou DAC Biotechnology Co., Ltd.Hangzhou DAC Biotechnology Co., Ltd.
Active Indication
Neoplasms
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
100 Clinical Results associated with CD56 x Top I
Login to view more data
100 Translational Medicine associated with CD56 x Top I
Login to view more data
0 Patents (Medical) associated with CD56 x Top I
Login to view more data
1
Literatures (Medical) associated with CD56 x Top I
01 Jan 1995Annals of the Rheumatic DiseasesQ1 · MEDICINE
Natural killer cells and gamma delta T cells in scleroderma: relationship to disease duration and anti-Scl-70 antibodies.
Q1 · MEDICINE

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free